Use of mycobacterium smegmatis trehalose dimycolate hydrolase
Methods are disclosed herein for treating an infection with a Mycobacterium infection. Methods are also disclosed for treating a Mycobacterium biofilm. The method include the use of trehalose dimycolate hydrolase, a variant thereof, or a nucleic acid encoding trehalose dimycolate hydrolase or a variant thereof Methods are also disclosed for detecting a Mycobacterium in a sample from a subject. The methods include treating the sample with trehalose dimycolate hydrolase or a variant thereof, and detecting a Mycobacterium nucleic acid in the sample.
1. A method of detecting Mycobacterium in a sample, comprising:
contacting a sample from a subject suspected of having a Mycobacterium infection with an effective amount of a trehalose dimycolate hydrolase comprising the amino acid sequence set forth as SEQ ID NO: 1 or SEQ ID NO: 2, wherein the trehalose dimycolate hydrolase hydrolyses trehalose, 6,6′-dimycolate to release nucleic acids comprising Mycobacterium RNA from the sample;
performing real-time polymerase chain reaction (PCR) on the nucleic acids comprising Mycobacterium RNA to amplify the Mycobacterium RNA into an amplified cDNA product; and
detecting the amplified cDNA product, wherein the presence of the amplified cDNA product indicates the presence of Mycobacterium in the sample, thereby detecting the Mycobacterium in the sample.
2. The method of claim 1 , wherein the trehalose dimycolate hydrolase consists of the amino acid sequence set forth as SEQ ID NO: 1 or SEQ ID NO: 2.
3. The method of claim 1 , wherein the Mycobacterium is M. tuberculosis, M. avium, M. marinum, M. bovis (BCG), or M. smegmatis.
4. The method of claim 1 , wherein the wherein the Mycobacterium is M. tuberculosis.
5. The method of any one of claim 1 , wherein the subject has a paucibacilliary infection.
6. The method claim 1 , wherein the subject is co-infected with a human immunodeficiency virus.
7. The method of claim 1 , wherein the sample is a sputum sample.
8. The method of claim 1 , wherein the PCR is a real-time PCR that amplifies 16S ribosomal RNA.
9. A method of detecting Mycobacterium tuberculosis in a sample, comprising:
contacting a sample from a subject suspected of having a Mycobacterium tuberculosis infection with an effective amount of a trehalose dimycolate hydrolase, wherein the trehalose dimycolate hydrolase comprises the amino acid sequence set forth as SEQ ID NO: 1 or SEQ ID NO: 2, and wherein the trehalose dimycolate hydrolase hydrolyses trehalose, 6,6′-dimycolate to release nucleic acids comprising Mycobacterium tuberculosis 16S ribosomal RNA from the sample;
performing real-time polymerase chain reaction on the nucleic acids comprising Mycobacterium tuberculosis 16S ribosomal RNA to amplify the Mycobacterium tuberculosis 16S ribosomal RNA into an amplified cDNA product; and
detecting the amplified cDNA product, wherein the presence of the amplified cDNA product indicates the presence of Mycobacterium tuberculosis in the sample.
10. The method of claim 9 , wherein the trehalose dimycolate consists of the amino acid sequence set forth as SEQ ID NO: 1 or SEQ ID NO: 2.
11. The method of claim 9 , wherein the sample is a sputum sample.
12. The method of claim 11 , further comprising clarifying the sputum sample prior to contacting the sputum sample with the trehalose dimycolate hydrolase.
13. The method of claim 12 , wherein clarifying the sputum sample comprises contacting the sputum sample with sodium hydroxide, sodium citrate and N-acetyl-L-cysteine.
14. The method of claim 9 , wherein the sample is contacted with the effective amount of the trehalose dimycolate hydrolase for about 30 to about 120 minutes.
15. The method of claim 9 , wherein the sample is contacted with about 50 to about 500 μg of trehalose dimycolate hydrolase at about 35° C. to about 39° C.
16. The method of claim 9 , wherein performing the real-time polymerase chain reaction comprises contacting the nucleic acids or the amplified cDNA with a forward and a reverse primer, wherein the forward primer comprises the nucleic acid sequence set forth as SEQ ID NO: 5 and the reverse primer comprises the nucleic acid sequence set forth as SEQ ID NO: 6.
17. The method of claim 16 , wherein performing the real-time polymerase chain reaction comprises contacting the nucleic acids or the amplified cDNA with a thermostable Taq DNA polymerase.
18. The method of claim 16 , wherein detecting the amplified cDNA product comprises contacting the amplified cDNA with a probe comprising the nucleic acid sequence set forth as SEQ ID NO: 7.